CD8A and lung cancer: In another study, Lakins et al. demonstrated in vitro that lung cancer CAFs presented antigens to CD8+ cells in an MHC I-dependent manner and suppressed their cytotoxic activity via expression of FAS- Ligand and Programed Death-Ligand 2 (PD-L2) [121].